Difference in Therapeutic Response Between Basal and Nonbasal Triple‐Negative Breast Cancers
نویسندگان
چکیده
منابع مشابه
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
PURPOSE Triple-negative (TN; estrogen receptor, progesterone receptor, and HER-2 negative) cancer and basal-like breast cancer (BLBC) are associated with poor outcome and lack the benefit of targeted therapy. It is widely perceived that BLBC and TN tumors are synonymous and BLBC can be defined using a TN definition without the need for the expression of basal markers. EXPERIMENTAL DESIGN We h...
متن کاملTriple negative, basal-like and BRCA1- associated breast cancers – what’s the difference and should anyone care?
Breast carcinoma is common in women and forms an integral part of the BRCA familial cancer syndromes. As breast cancer is considered a heterogeneous disease, clinicians have traditionally relied on clinical and morphologic findings, as well as hormone receptor/HER-2 status for prognostic and predictive categorisation of tumours. Recently, breast cancer subclassification has been aided by the di...
متن کاملA comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
BACKGROUND Breast carcinomas can be classified into five subtypes based on gene expression profiling or immunohistochemical characteristics. Among these subtypes, basal-like breast carcinomas (BLBCs) are one of the most studied group, due to their poor prognosis. The aim of this study was to investigate the prevalance, morphological and immunohistochemical features of BLBCs, in Turkish populati...
متن کاملIntegrated profiling of basal and luminal breast cancers.
Basal and luminal are two molecular subtypes of breast cancer with opposite histoclinical features. We report a combined, high-resolution analysis of genome copy number and gene expression in primary basal and luminal breast cancers. First, we identified and compared genomic alterations in 45 basal and 48 luminal tumors by using 244K oligonucleotide array comparative genomic hybridization (aCGH...
متن کاملAndrogen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
Triple negative breast cancers are a heterogeneous group of tumors characterized by poor patient survival and lack of targeted therapeutics. Androgen receptor has been associated with triple negative breast cancer pathogenesis, but its role in the different subtypes has not been clearly defined. We examined androgen receptor protein expression by immunohistochemical analysis in 678 breast cance...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 2013
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2013-0121